Department of Cellular and Molecular Pharmacology and Howard Hughes Medical Institute, University of California, San Francisco, California 94158, United States.
NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland 21701, United States.
ACS Chem Biol. 2023 Sep 15;18(9):2082-2093. doi: 10.1021/acschembio.3c00413. Epub 2023 Aug 14.
Protein-membrane interactions (PMIs) are ubiquitous in cellular signaling. Initial steps of signal transduction cascades often rely on transient and dynamic interactions with the inner plasma membrane leaflet to populate and regulate signaling hotspots. Methods to target and modulate these interactions could yield attractive tool compounds and drug candidates. Here, we demonstrate that the conjugation of a medium-chain lipid tail to the covalent K-Ras(G12C) binder MRTX849 at a solvent-exposed site enables such direct modulation of PMIs. The conjugated lipid tail interacts with the tethered membrane and changes the relative membrane orientation and conformation of K-Ras(G12C), as shown by molecular dynamics (MD) simulation-supported NMR studies. In cells, this PMI modulation restricts the lateral mobility of K-Ras(G12C) and disrupts nanoclusters. The described strategy could be broadly applicable to selectively modulate transient PMIs.
蛋白质-膜相互作用(PMIs)在细胞信号转导中普遍存在。信号转导级联的初始步骤通常依赖于与内质膜小叶的瞬时和动态相互作用,以填充和调节信号热点。靶向和调节这些相互作用的方法可能会产生有吸引力的工具化合物和药物候选物。在这里,我们证明了在溶剂暴露的位点将中链脂质尾巴连接到共价 K-Ras(G12C)结合物 MRTX849 上,能够直接调节 PMIs。共轭脂质尾巴与连接的膜相互作用,并改变 K-Ras(G12C)的相对膜取向和构象,这一点通过支持 MD 模拟的 NMR 研究得到了证明。在细胞中,这种 PMI 调节限制了 K-Ras(G12C)的侧向流动性并破坏了纳米簇。所描述的策略可能广泛适用于选择性调节瞬时 PMIs。